Rajani Dinavahi
Vermogen: 759 780 $ op 31-08-2026
Vermogen: 759 780 $ op 31-08-2026
Rajani Dinavahi is currently Chief Medical Officer at Ardelyx, Inc. since 2026.
Formerly, Dr. Dinavahi was Chief Medical Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2024 to 2025.
Education includes undergraduate and doctorate degrees from the University of Miami.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARDELYX, INC. 0,08% | 01-04-2026 | 201.000 ( 0,08% ) | 759 780 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARDELYX, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2025 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau